版本:
中国

BRIEF-Egalet announces U.S. FDA acceptance of file for prior approval supplement for Oxaydo

April 18 Egalet Corp

* Egalet announces U.S. Food and Drug Administration acceptance of file for prior approval supplement for Oxaydo(oxycodone HCL, USP) tablets C-II 10 mg and 15 mg dosage strengths

* Egalet Corp - FDA goal date is June 17, 2017

* Egalet Corp - there is no evidence that Oxaydo has reduced abuse liability compared to immediate-release oxycodone Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐